Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Receptors: Cell Surface Receptors01:28

Types of Receptors: Cell Surface Receptors

27.4K
Cell-surface receptors, also known as transmembrane receptors, are cell surface, membrane-anchored (integral) proteins that bind to external ligand molecules. This type of receptor spans the plasma membrane and performs signal transduction, converting an extracellular signal into an intracellular signal. Ligands that interact with cell-surface receptors do not have to enter the cell that they affect. Cell-surface receptors are also called cell-specific proteins or markers because they are...
27.4K
Affinity and Avidity01:41

Affinity and Avidity

39.0K
Overview
39.0K
Electron Affinity03:07

Electron Affinity

43.3K
The electron affinity (EA) is the energy change for adding an electron to a gaseous atom to form an anion (negative ion).
43.3K
Internal Receptors01:31

Internal Receptors

74.6K
Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
74.6K
Ionic Bonding and Electron Transfer02:48

Ionic Bonding and Electron Transfer

49.1K
Ions are atoms or molecules bearing an electrical charge. A cation (a positive ion) forms when a neutral atom loses one or more electrons from its valence shell, and an anion (a negative ion) forms when a neutral atom gains one or more electrons in its valence shell. Compounds composed of ions are called ionic compounds (or salts), and their constituent ions are held together by ionic bonds: electrostatic forces of attraction between oppositely charged cations and anions. 
49.1K
Receptor-mediated Endocytosis01:39

Receptor-mediated Endocytosis

110.9K
Overview
110.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cytokine co-presentation on targeted lipid nanoparticles enhances in vivo T cell engineering.

Biomaterials·2026
Same author

Oversimplified immunology is holding biomaterials back.

Nature reviews bioengineering·2026
Same author

Lipid nanoparticle composition directs systemic trafficking and tissue-specific T cell immunity after intramuscular injection.

Nature biomedical engineering·2026
Same author

Engineering age-adaptive mRNA lipid nanoparticle cancer vaccines via reprogramming systemic gene expression.

bioRxiv : the preprint server for biology·2026
Same author

Biodegradable targeted polymeric mRNA nanoparticles enable in vivo CD19 CAR T cell generation and lead to B cell depletion.

Science advances·2026
Same author

Class II Peptide-Major Histocompatibility Complex Lipid Nanoparticles Enable in vivo mRNA Delivery to Antigen-Specific CD4<sup>+</sup> T Cells.

ACS applied materials & interfaces·2026

Related Experiment Video

Updated: Feb 1, 2026

Isolation and Adoptive Transfer of High Salt Treated Antigen-presenting Dendritic Cells
09:29

Isolation and Adoptive Transfer of High Salt Treated Antigen-presenting Dendritic Cells

Published on: March 5, 2019

6.1K

High-affinity T cell receptors for adoptive cell transfer.

Ariel Isser1, Jonathan P Schneck2,3

  • 1Department of Biomedical Engineering.

The Journal of Clinical Investigation
|December 12, 2018
PubMed
Summary

Engineered T cell receptors (TCRs) enhance cancer immunotherapy. Researchers identified optimal affinity CD4+ TCRs for NY-ESO-1, demonstrating T cell help is crucial for effective antitumor responses in adoptive cell transfer therapy.

More Related Videos

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

16.0K
Assessing the Development of Murine Plasmacytoid Dendritic Cells in Peyer's Patches Using Adoptive Transfer of Hematopoietic Progenitors
13:34

Assessing the Development of Murine Plasmacytoid Dendritic Cells in Peyer's Patches Using Adoptive Transfer of Hematopoietic Progenitors

Published on: March 17, 2014

11.5K

Related Experiment Videos

Last Updated: Feb 1, 2026

Isolation and Adoptive Transfer of High Salt Treated Antigen-presenting Dendritic Cells
09:29

Isolation and Adoptive Transfer of High Salt Treated Antigen-presenting Dendritic Cells

Published on: March 5, 2019

6.1K
Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

16.0K
Assessing the Development of Murine Plasmacytoid Dendritic Cells in Peyer's Patches Using Adoptive Transfer of Hematopoietic Progenitors
13:34

Assessing the Development of Murine Plasmacytoid Dendritic Cells in Peyer's Patches Using Adoptive Transfer of Hematopoietic Progenitors

Published on: March 17, 2014

11.5K

Area of Science:

  • Immunology
  • Oncology
  • Biotechnology

Background:

  • Adoptive cell transfer (ACT) using engineered T cell receptors (TCRs) is a promising cancer immunotherapy.
  • TCR affinity must be optimized to overcome tolerance and enhance efficacy.
  • Cancer testis antigen (CTA) NY-ESO-1 is a target for immunotherapy.

Purpose of the Study:

  • To discover CD4+ TCRs with optimal affinity for the CTA NY-ESO-1.
  • To evaluate the role of T cell help in ACT for cancer immunotherapy.
  • To investigate the combined efficacy of CD4+ and CD8+ TCRs against fibrosarcoma.

Main Methods:

  • Utilized mice engineered with human TCRαβ and HLA gene loci.
  • Identified and characterized CD4+ TCRs specific for NY-ESO-1.
  • Employed an ACT fibrosarcoma tumor model with combined CD4+ and CD8+ TCRs.

Main Results:

  • Discovered CD4+ TCRs with optimal affinity for NY-ESO-1.
  • Demonstrated that CD4+ T cell help is essential for potent antitumor responses.
  • Showcased the importance of TCR affinity in adoptive cell transfer therapy.

Conclusions:

  • Optimized TCR affinity is critical for effective cancer immunotherapy via ACT.
  • CD4+ T cell help plays a vital role in mediating antitumor immunity.
  • Combined CD4+ and CD8+ TCR strategies hold promise for cancer treatment.